KK3910

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KK3910, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension [Phase 1]